封面
市場調查報告書
商品編碼
1442896

寵物照護糖尿病藥物市場(產品類型:胰島素藥物、SGLT2 抑制劑等;動物類型:貓和狗)- 全球產業分析、規模、佔有率、成長、趨勢和預測,2023-2031 年

Pet Care Diabetes Drugs Market (Product Type: Insulin Drugs, SGLT2 Inhibitors, and Others; and Animal Type: Cats and Dogs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日期: | 出版商: Transparency Market Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

寵物護理糖尿病藥物市場 - 報告範圍

TMR 關於與阿茲海默症相關的全球失智症市場的報告研究了過去以及當前的成長趨勢和機會,以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球失智症的收入與 2017-2031 年期間阿茲海默症市場相關,考慮 2023 年為基準年,2031 年為預測年。該報告還提供了2023年至2031年全球與阿茲海默症相關的失智症市場的年複合成長率(CAGR %)。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作,其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件,以了解與阿茲海默症相關的失智症市場。

該報告深入研究了與阿茲海默症相關的全球失智症市場的競爭格局。與阿茲海默症相關的全球失智症市場的主要參與者已被確定,並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球失智症相關市場參與者的屬性。

目錄

第1章:前言

第 2 章:假設與研究方法

第 3 章:執行摘要:全球市場

第 4 章:市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017 - 2031 年全球市場分析與預測

第 5 章:關鍵見解

  • 寵物糖尿病的流行病學
  • 重要行業活動
  • COVID-19 大流行對該行業的影響

第 6 章:全球市場分析與預測:依動物類型

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按動物類型分類的市場價值預測
    • 小狗
  • 按動物類型分類的市場吸引力

第 7 章:全球市場分析與預測:依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按產品類型分類的市場價值預測
    • 胰島素藥物
    • SGLT2 抑制劑
    • 其他
  • 按產品類型分類的市場吸引力

第 8 章:全球市場分析與預測:按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年最終用戶市場價值預測
    • 獸醫醫院藥房
    • 零售藥局
    • 其他
  • 最終用戶的市場吸引力

第 9 章:全球市場分析與預測:按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 世界其他地區
  • 按國家/地區分類的市場吸引力

第 10 章:北美市場分析與預測

第 11 章:歐洲市場分析與預測

第 12 章:世界其他地區市場分析與預測

第 13 章:競爭格局

  • 市場參與者 - 競爭矩陣(依公司層級和規模)
  • 公司市佔率分析 (2022)
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Elanco
    • Merck Animal Health
Product Code: TMRGL85929

Pet Care Diabetes Drugs Market - Scope of Report

TMR's report on the global dementia associated with Alzheimer's disease market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global dementia associated with Alzheimer's disease market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dementia associated with Alzheimer's disease market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dementia associated with Alzheimer's disease market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dementia associated with Alzheimer's disease market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global dementia associated with Alzheimer's disease market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dementia associated with Alzheimer's disease market.

The report delves into the competitive landscape of the global dementia associated with Alzheimer's disease market. Key players operating in the global dementia associated with Alzheimer's disease market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dementia associated with Alzheimer's disease market profiled in this report.

Key Questions Answered in Global dementia associated with Alzheimer's disease Market Report:

  • What is the sales/revenue generated by dementia associated with Alzheimer's disease across all regions during the forecast period?
  • What are the opportunities in the global dementia associated with Alzheimer's disease market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Pet Care Diabetes Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global dementia associated with Alzheimer's disease market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dementia associated with Alzheimer's disease market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dementia associated with Alzheimer's disease market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pet Care Diabetes Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Epidemiology of Diabetes in Pets
  • 5.2. Key Industry Events
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Animal Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Animal Type, 2017 - 2031
    • 6.3.1. Cats
    • 6.3.2. Dogs
  • 6.4. Market Attractiveness By Animal Type

7. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Product Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Product Type, 2017 - 2031
    • 7.3.1. Insulin Drugs
    • 7.3.2. SGLT2 Inhibitors
    • 7.3.3. Others
  • 7.4. Market Attractiveness By Product Type

8. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2017 - 2031
    • 8.3.1. Vet Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Pet Care Diabetes Drugs Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Rest of World
  • 9.3. Market Attractiveness By Country/Region

10. North America Pet Care Diabetes Drugs Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 10.2.1. Cats
    • 10.2.2. Dogs
  • 10.3. Market Value Forecast By Product Type, 2017 - 2031
    • 10.3.1. Insulin Drugs
    • 10.3.2. SGLT2 Inhibitors
    • 10.3.3. Others
  • 10.4. Market Value Forecast By End-user, 2017 - 2031
    • 10.4.1. Vet Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2017 - 2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Animal Type
    • 10.6.2. By Product Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pet Care Diabetes Drugs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 11.2.1. Cats
    • 11.2.2. Dogs
  • 11.3. Market Value Forecast By Product Type, 2017 - 2031
    • 11.3.1. Insulin Drugs
    • 11.3.2. SGLT2 Inhibitors
    • 11.3.3. Others
  • 11.4. Market Value Forecast By End-user, 2017 - 2031
    • 11.4.1. Vet Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country, 2017 - 2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Animal Type
    • 11.6.2. By Product Type
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Rest of World Pet Care Diabetes Drugs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Animal Type, 2017 - 2031
    • 12.2.1. Cats
    • 12.2.2. Dogs
  • 12.3. Market Value Forecast By Product Type, 2017 - 2031
    • 12.3.1. Insulin Drugs
    • 12.3.2. SGLT2 Inhibitors
    • 12.3.3. Others
  • 12.4. Market Value Forecast By End-user, 2017 - 2031
    • 12.4.1. Vet Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Others
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Animal Type
    • 12.5.2. By Product Type
    • 12.5.3. By End-user

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 13.2. Market Share Analysis By Company (2022)
  • 13.3. Company Profiles
    • 13.3.1. Boehringer Ingelheim International GmbH
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Elanco
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. SWOT Analysis
      • 13.3.2.5. Strategic Overview
    • 13.3.3. Merck Animal Health
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. SWOT Analysis
      • 13.3.3.5. Strategic Overview

List of Tables

  • Table 01: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 02: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 03: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 07: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 11: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 14: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Pet Care Diabetes Drugs Market Size, by Animal Type, 2022
  • Figure 02: Global Pet Care Diabetes Drugs Market share (%), by Animal Type, 2022
  • Figure 03: Global Pet Care Diabetes Drugs Market Size, by Product Type, 2022
  • Figure 04: Global Pet Care Diabetes Drugs Market share (%), by Product Type, 2022
  • Figure 05: Global Pet Care Diabetes Drugs Market Size, by End-user, 2022
  • Figure 06: Global Pet Care Diabetes Drugs Market share (%), by End-user, 2022
  • Figure 07: Global Pet Care Diabetes Drugs Market, by Region (2022 and 2031)
  • Figure 08: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 10: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022
  • Figure 11: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2031
  • Figure 12: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 13: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 14: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022
  • Figure 15: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2031
  • Figure 16: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 17: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 18: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 19: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 20: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 21: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
  • Figure 22: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 23: Global Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 24: Global Pet Care Diabetes Drugs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 26: North America Pet Care Diabetes Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 29: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 30: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 31: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-31
  • Figure 32: North America Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 33: North America Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: Europe Pet Care Diabetes Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 36: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 37: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 38: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 39: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 40: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 41: Europe Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 42: Europe Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 43: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Animal Type, 2022 and 2031
  • Figure 45: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 46: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by Product Type, 2022 and 2031
  • Figure 47: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 48: Rest of World Pet Care Diabetes Drugs Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 49: Rest of World Pet Care Diabetes Drugs Market Attractiveness Analysis, by End-user, 2023-2031